Related Experiment Video

Updated: May 21, 2026

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
10:21

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Published on: February 21, 2018

Blocking p55PIK signaling inhibits proliferation and induces differentiation of leukemia cells

G Wang1, Y Deng, X Cao

  • 1Cancer Research Institute, Tongji Hospital, Huazhong University of Science and Technology, Wuhan 430030, China.

Cell Death and Differentiation
|June 23, 2012
PubMed

Insights

A novel fusion protein, Tat transactivator protein (TAT)-N24, effectively halts leukemia cell proliferation and remarkably induces differentiation. This suggests p55PIK as a potential drug target for hematopoetic malignancies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • p55PIK, a phosphatidylinositol 3-kinase regulatory subunit, promotes cell cycle progression through interactions with proteins like retinoblastoma protein (Rb).
  • The N24 domain of p55PIK is crucial for these interactions; its overexpression causes cell cycle arrest.

Purpose of the Study:

  • To investigate the therapeutic potential of a novel fusion protein, TAT-N24, in leukemia treatment.
  • To evaluate TAT-N24's effects on leukemia cell proliferation and differentiation in vitro and in vivo.

Main Methods:

  • Generation of a fusion protein (TAT-N24) combining a protein transduction domain with the N24 peptide.
  • Assessment of TAT-N24's impact on leukemia cell proliferation, differentiation, and tumor growth in animal models.
  • Analysis of p55PIK expression in patient-derived leukemia cells and bone marrow cells.

Main Results:

  • TAT-N24 effectively inhibits leukemia cell proliferation and induces differentiation both in vitro and in vivo.
  • Systemic administration of TAT-N24 significantly reduces leukemia tumor growth in animal models.
  • TAT-N24 counteracts p55PIK-induced proliferation and promotes differentiation in leukemia cells, including those from patients.

Conclusions:

  • Cell-permeable TAT-N24 peptide is a potent inducer of leukemia cell differentiation.
  • p55PIK represents a promising novel drug target for treating hematopoetic malignancies.

More Related Videos

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

Preparation of Primary Acute Lymphoblastic Leukemia Cells in Different Cell Cycle Phases by Centrifugal Elutriation09:09

Preparation of Primary Acute Lymphoblastic Leukemia Cells in Different Cell Cycle Phases by Centrifugal Elutriation

Published on: November 10, 2017

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...